Month: <span>June 2020</span>

Home / 2020 / June
Clear signs of brain injury with severe COVID-19
Post

Clear signs of brain injury with severe COVID-19

CREDIT: PHOTO BY JOHAN WINGBORG Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible. Some people infected with the coronavirus SARS-CoV-2 get...

Nanofiber masks can be sterilized multiple times without filter performance deterioration
Post

Nanofiber masks can be sterilized multiple times without filter performance deterioration

CREDIT: COPYRIGHT ©2020 AMERICAN CHEMICAL SOCIETY With the global spread of coronavirus infections, personal protective equipments especially hygeine face masks are receiving much attention. Masks are essential items for the primary protection of the respiratory tract from viruses and bacteria that are transmitted through the air as droplets. N95 masks are currently difficult to obtain,...

Post

EULAR: Early and intensive treatment of rheumatoid arthritis reduces fatigue

Better quality of life for people with rheumatic and musculoskeletal diseases EUROPEAN LEAGUE AGAINST RHEUMATISM Kilchberg/Switzerland: Disease-related, profound fatigue impairs the quality of life of many people with rheumatic and musculoskeletal diseases. A Belgian study (1) has now concluded that early intensive treatment combining methotrexate with a bridging scheme of prednisone can reduce the onerous...

Premature epigenomic aging acts like a ‘sleeper cell’ that is awakened by Western-style diet
Post

Premature epigenomic aging acts like a ‘sleeper cell’ that is awakened by Western-style diet

by Baylor College of Medicine The epigenome is sometimes referred to as the “software” or “operating system” of the genome. It comprises small chemical modifications to DNA and the proteins that make up our chromosomes, and controls the activity of all the genes within the genome. During early life, as our organs develop, the epigenome...

COVID-19 study good news for rheumatic disease patients on immunosuppressants
Post

COVID-19 study good news for rheumatic disease patients on immunosuppressants

A European League Against Rheumatism (EULAR) database containing information on the effects of COVID-19 on patients with rheumatic and musculoskeletal diseases has given some reassurance to patients taking immunosuppressants. The drugs studied by the team include anti-malarial drugs, methotrexate, biological therapies such as TNF-alpha inhibitors, and nonsteroidal anti-inflammatory drugs such as Naproxen. None of them...